Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets close in 43 minutes
FTSE 100
8,171.68
+24.65
(+0.30%)
FTSE 250
20,041.87
-42.92
(-0.21%)
AIM
761.73
-1.60
(-0.21%)
GBP/EUR
1.1704
-0.0008
(-0.07%)
GBP/USD
1.2523
-0.0039
(-0.31%)
Bitcoin GBP
50,119.69
-539.11
(-1.06%)
Stocks
Trending tickers: Amazon, Tesla, Samsung, Mercedes-Benz, Whitbread
The latest investor updates on stocks that are trending on Tuesday
C4 Therapeutics, Inc. (CCCC)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.26
-0.06
(-0.95%)
As of 10:45AM EDT. Market open.
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
20,756
20,756
31,096
45,785
33,195
Operating expenses
Research development
117,706
117,706
117,841
94,665
78,440
Selling general and administrative
42,081
42,081
42,789
33,254
15,204
Total operating expenses
159,787
159,787
160,630
127,919
93,644
Operating income or loss
-139,031
-139,031
-129,534
-82,134
-60,449
Interest expense
1,373
1,373
2,216
2,145
1,229
Total other income/expenses net
-621
-621
-
-
-5,676
Income before tax
-131,213
-131,213
-128,175
-83,892
-66,961
Income tax expense
1,280
1,280
0
0
-626
Income from continuing operations
-132,493
-132,493
-128,175
-83,892
-66,335
Net income
-132,493
-132,493
-128,175
-83,892
-66,335
Net income available to common shareholders
-132,493
-132,493
-128,175
-83,892
-66,335
Basic EPS
-2.75
-
-2.62
-1.82
-5.83
Diluted EPS
-2.75
-
-2.62
-1.82
-5.83
Basic average shares
49,069
-
48,862
46,042
11,370
Diluted average shares
49,069
-
48,862
46,042
11,370
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.